Yurgin Advisory GmbH – Services Overview

At Yurgin Advisory, I bring two decades of experience helping life science companies and investors navigate the complex world of market access and evidence generation. Each engagement is led by me personally, ensuring senior-level expertise, strategic clarity, and a practical approach grounded in real-world success. My goal is to help clients turn data into insight and strategy into patient impact.

RWE / HEOR Evidence Planning & Execution

From early evidence strategy to post-launch studies, I help clients design and execute programs that resonate with payers and decision-makers.

Access Strategy & Launch Planning

Effective access strategy starts well before launch. I work with clients to anticipate payer expectations, integrate early pricing and policy insights, and develop launch strategies that align evidence, value, and communication.

Value Communication

Every product has a story but communicating its value clearly and credibly is what drives access and adoption. I help clients distill complex evidence into messages that resonate with payers, investors, and policy audiences alike.

Asset & Portfolio Due Diligence

I provide strategic insight to investors, boards, and biopharma leaders evaluating assets or portfolios through a market access lens. My experience across global evidence and pricing enables me to identify the assumptions and risks that most affect value and commercial potential.